Clinical Trials Logo

Cirrhosis clinical trials

View clinical trials related to Cirrhosis.

Filter by:

NCT ID: NCT00999167 Completed - Cirrhosis Clinical Trials

A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy

HALT-HE
Start date: December 2009
Phase: Phase 2
Study type: Interventional

This is a phase 2 study of HPN-100 in subjects with hepatic encephalopathy (HE) consisting of an open label safety lead-in (Part A), followed by randomized, double-blind, placebo-controlled treatment (Part B).

NCT ID: NCT00986817 Completed - Cirrhosis Clinical Trials

Terlipressin in Cirrhotic Patients With Recidivation Ascites Treated With Paracentesis and Albumin

TERAS
Start date: November 2009
Phase: Phase 3
Study type: Interventional

Ascites is a common complication of cirrhosis. Sodium restriction and diuretics are the first step treatment. Refractory ascites (not responding to first step treatment) is treated with repeated large volume paracentesis followed by intra venous albumin expansion. In pilot studies vasoconstrictor agents such as terlipressin have shown beneficial effect on ascites production. Therefore the investigators will study the effect of combined therapy with albumin and terlipressin on recidivation ascites.

NCT ID: NCT00968695 Completed - Cirrhosis Clinical Trials

Effects of Long Term Albumin 20% Administration in Patients With Cirrhosis and Ascites.

Start date: July 2009
Phase: Phase 4
Study type: Interventional

Effects of long term albumin administration on the cardiocirculatory and renal function and hepatic hemodynamics in patients with advanced cirrhosis and ascites.

NCT ID: NCT00966121 Recruiting - Cirrhosis Clinical Trials

Endoscopic Band Ligation (EBL) Versus Endoscopic Band Ligation and Propranolol for the Prevention of Variceal Rebleeding

Start date: August 2008
Phase: Phase 4
Study type: Interventional

Both propranolol and endoscopic band ligation (EBL) are effective for prevention of variceal rebleeding. Recently several studies compared the efficacy of EBL alone and with a combination of propranolol and EBL. However, the results of recent studies showed discrepancy. This study is performed to compare the efficacy and safety of EBL alone and EBL combined with propranolol in patients without previous history of endoscopic variceal treatment.

NCT ID: NCT00966082 Recruiting - Cirrhosis Clinical Trials

EBL Versus EBL and Propranolol for the Prevention of Variceal Rebleeding in Pts With Previous Variceal Treatment

Start date: August 2008
Phase: Phase 4
Study type: Interventional

This study is performed to compare the efficacy and safety of EBL alone and EBL combined with propranolol in patients who were previously performed endoscopic variceal treatment.

NCT ID: NCT00965900 Recruiting - Cirrhosis Clinical Trials

Endoscopic Band Ligation (EBL) Versus Propranolol for Primary Prophylaxis of Variceal Bleeding

Start date: September 2006
Phase: Phase 4
Study type: Interventional

This study is performed to compare the efficacy and safety of EBL, propranolol, and EBL combined with propranolol in patients with medium or large varices.

NCT ID: NCT00926224 Completed - Cirrhosis Clinical Trials

Fibroscan® and Its Dedicated Probes Efficiency in Obese Patients

Start date: July 2009
Phase: N/A
Study type: Interventional

The main objective of the study is to evaluate the diagnostic performance of the XL probe for estimating degree of liver fibrosis/cirrhosis in obese patients > 28 kg/m² with various liver diseases in patients with chronic liver disease scheduled for a liver biopsy.

NCT ID: NCT00921349 Completed - Cirrhosis Clinical Trials

A Trial of Ligation Plus Nadolol Versus Nadolol Alone in the Prophylaxis of First Variceal Bleeding in Cirrhosis

Start date: December 2004
Phase: Phase 4
Study type: Interventional

The value of banding ligation plus beta blocker in the prophylaxis of first episodes of variceal bleeding has not yet been evaluated. This study was conducted to compare the efficacy and safety of banding ligation plus nadolol versus nadolol in the prophylaxis of first bleeding in cirrhotic patients with high-risk esophageal varices.

NCT ID: NCT00906139 Unknown status - Cirrhosis Clinical Trials

Propofol and Fentanyl Versus Midazolam and Fentanyl for Endoscopy Sedation in Cirrhotic Patients

Start date: March 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare propofol associated with fentanyl versus midazolam plus fentanyl for sedation during diagnosis or therapeutic upper gastrointestinal endoscopy (UGE) in cirrhotic patients.

NCT ID: NCT00905996 Completed - Cirrhosis Clinical Trials

Primary Prophylaxis of Gastric Varix Bleed

Start date: August 2006
Phase: N/A
Study type: Interventional

In patients who have never bled from gastric varix (GOV2 and IGV1), cyanoacrylate injection will be better than both beta-blocker therapy and no treatment in prevention of gastric variceal bleed. The investigators conducted a randomized controlled trial in patients with gastric varix (GOV2 and IGV1) who never bled before, to study the efficacy of treatment with cyanoacrylate injection versus beta-blocker versus no treatment in prevention of first bleed from gastric varices.